Grown Rogue International (GRUSF) Property, Plant & Equipment (Net) Growth (1y) (2012 - 2026)
Grown Rogue International (GRUSF) Property, Plant & Equipment (Net) Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | -18.34% |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 6.19% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -0.59% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 41.67% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -7.68% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | -1.31% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.98% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 3.94% |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 52.14% |
| Mar 31, 2026 | 30.62% |
| Dec 31, 2025 | 0.08% |
| Sep 30, 2025 | 142,784,980.64% |
| Jun 30, 2025 | 71.26% |
| Mar 31, 2025 | 19.51% |
| Dec 31, 2024 | 116.76% |
| Oct 31, 2023 | 50.31% |
| Oct 31, 2022 | -34.07% |
| Oct 31, 2021 | 187.78% |
| Apr 30, 2021 | 71.66% |
| Jan 31, 2021 | -17.82% |
| Oct 31, 2020 | 1,222.76% |
| Jul 31, 2020 | -3.76% |
| Apr 30, 2020 | -4.79% |
| Jan 31, 2020 | -16.75% |
| Oct 31, 2019 | -88.84% |
| Apr 30, 2019 | -11.50% |
| Oct 31, 2018 | 100.83% |
| Aug 31, 2012 | -30.84% |